Sepsis Treatment Market

Sepsis Treatment Market (Type: Severe Sepsis, Septic Shock, and Sepsis in Need of Blood Purification; Therapy: Continuous Renal Replacement Therapies [CRRT], Intermittent Hemodialysis, Sustained Low-efficiency Daily Dialysis [SLEDD], and Others; and End User: Hospitals, Specialty Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Can COVID-19 Pneumonia Lead to Severe Septic Shock in Patients?

The Global Sepsis Alliance has stated that the novel coronavirus may lead to sepsis by affecting the body’s immune system response toward the infection, resulting in organ damage and even death. Such developments are creating revenue opportunities for stakeholders in the sepsis treatment market. COVID-19 pneumonia is one of the major factors to cause sepsis in patients, owing to severe lung inflammation that occurs in response to the novel infection.

Bacterial, fungal, and viral infections have the possibility to cause coronavirus pneumonia, thus leading to sepsis. It has been found that patients with severe COVID-19 from Seattle reported severe septic shock, which triggered the demand for drugs to support heart and blood circulation. This has compelled companies in the sepsis treatment market to ensure the availability of treatments and medical supplies to improve patient quality of life.

To know the scope of our report Get a Sample on Sepsis Treatment Market

Severity of AKI, Presence of Electrolyte Disorders Influence Outcomes after CRRT

Continuous Renal Replacement Therapy (CRRT) is considered as the gold standard for sepsis syndromes. However, complications of CRRT such as risks associated with intravascular lines such as hemorrhage, infection or thrombosis need to be communicated to the patient or the family, while considering initiation. Stakeholders in the sepsis treatment market are working closely with healthcare professionals to troubleshoot problems of CRRT by considering factors including severity of illness and necessity of the procedure to reduce morbidity and mortality rates.

CRRT is linked with electrolyte disturbances and hypothermia in patients. Hence, clinicians are considering various factors such as judging the severity of acute kidney injury (AKI) and the presence of electrolyte or acid-base disorders to improve medical outcomes.

Get a glimpse of the in-depth analysis through our Report Brochure

Heparin-free RRT Anticoagulation Strategy Decreases Risk of Bleeding in Patients

The global sepsis treatment market is expected to reach US$ 1.6 Bn by the end of 2031. The high number of sepsis patients in the U.S. is creating stable revenue streams for stakeholders. Though CRRT dominates most sepsis procedures in intensive care units (ICUs), there is a significant demand for intermittent hemodialysis (IHD) for the treatment of patients.

Anticoagulation is required for renal replacement therapy (RRT) to prevent clotting of the extracorporeal circuit. On the other hand, systematic heparin anticoagulation is commonly used during IHD. However, this procedure increases the risk of bleeding and results in high ICU mortality rates. In order to overcome this issue, companies in the sepsis treatment market are offering heparin-free RRT anticoagulation strategy for patients.

Companies to Collaborate with Researchers to Advance in Sepsis Diagnosis

The European Sepsis Academy (ESA-ITN) is gaining recognition for advancements in sepsis diagnosis and treatment. This research project involves a training network that assists in diagnosis of sepsis through biomarker diagnostics and clinical trial models. Companies in the sepsis treatment market are taking cues from such research projects and collaborating with researchers to gain information on pathogenesis of sepsis-induced immune suppression and the development of diagnostic platforms.

Companies in the sepsis treatment market are increasing their research in identification and validation of diagnostic markers. They are gaining emphasis on regulatory mechanisms that drive inflammation and immunosuppression during sepsis.

ML-based Sepsis Detection, Management Platform Exhibit Potential to Improve Patient Outcomes

The sepsis deep learning technology is expected to bring a significant change in the global sepsis treatment market. This has led to the popularity of Sepsis Watch, which was developed in November 2018, and serves as a sepsis detection and management platform that can be used by clinicians to improve compliance with recommended treatment guidelines for sepsis. However, there is a need for new mechanisms of trust and accountability that must be developed to ensure that the systems are safe and reliable. Such platforms hold promising potentials to improve patient outcomes and create value grab opportunities for companies in the sepsis treatment market.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The COVID-19 pandemic has resulted in high mortality of patients who were previously and are currently diagnosed with sepsis. CRRT has the potential to prevent worsening of cerebral edema in patients. However, CRRT is associated with electrolyte disturbances and hypotention. Hence, stakeholders in the sepsis treatment market should increase awareness about the adoption of an inter-professional approach to provide safe and efficient CRRT in patients and reduce incidence of complications. Companies in the sepsis treatment market are increasing efforts to learn the health system framework and previously described best practices for bringing in routine and responsible machine learning (ML) in healthcare. They should collaborate with researchers to prevent post-sepsis sequelae and post-sepsis pathways to optimize treatment.

Sepsis Treatment Market: Overview

  • The global sepsis treatment market was valued over US$ 600 Mn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031. Growth of the sepsis treatment market can be attributed to increase in patient population with infectious diseases such as COVID-19 and acute kidney injury; rise in investment by pharmaceutical and biotechnology companies in drug discovery; and surge in launch of new products for the treatment of sepsis.
  • Presence of key players with technologically advanced products and strong geographic presence are anticipated to propel the global sepsis treatment market. Key industry events, including partnerships, mergers & acquisitions, and collaborations, are expected to fuel the growth of the global sepsis treatment market.
  • According to United Nations University (UNU) estimates, the percentage of the world population above 65 years of age is anticipated to increase from 9% in 2010 to 16% by 2050. Hence, increase in the population above 65 years of age asserts the need of safe and effective therapeutics for sepsis treatment. Therefore, rise in population of this group is a major driver of the market.
  • Increase in number of product launches and collaborations among players is a major factor propelling of the global sepsis treatment market
  • Large number of drugs are under different phases of clinical trials for the treatment of sepsis. Leading companies have made significant investments in clinical R&D and have established strategic partnerships and collaborations to accelerate new product development.
  • Asahi Kasei Corporation’s ART-123 is currently in phase III clinical trial and is expected to launch in the first half of 2021
  • Altor BioScience is developing anti-TF antibody (ALT-836) to treat septic patients with acute lung injury or acute respiratory distress syndrome

Sepsis Treatment Market: Segmentation

  • The global sepsis treatment market has been segmented based on type, therapy, end user, and region
  • In terms of type, the global sepsis treatment market has been classified into severe sepsis, septic shock, and sepsis in need of blood purification. The severe sepsis segment accounted for significant share of the global market in 2020. The segment's dominance can be attributed to increase in patient population with infectious diseases such as COVID-19. According to the Global Sepsis Alliance, signs of multi-organ injury, typical of severe sepsis, occur in 2% to 5% of patients with COVID-19 after eight to 10 days.
  • Based on therapy, the global sepsis treatment market has been categorized into continuous renal replacement therapies (CRRT), intermittent hemodialysis, sustained low-efficiency daily dialysis (SLEDD), and others. The continuous renal replacement therapies (CRRT) segment dominated the global sepsis treatment market in 2020. Increase in demand for CRRT devices for acute dialysis and various strategic decisions taken by various firms to increase CRRT production are expected to drive the segment during the forecast period. For instance, Baxter has taken a strategic decision to maximize its supply of CRRT devices, fluids, and sets to counter the unprecedented increase in demand for its acute dialysis products in Europe and the U.S.
  • In terms of end user, the global sepsis treatment market has been divided into hospitals, specialty centers, and others. The hospitals segment accounted for major share of the market in 2020. Hospitals are an important channel for sepsis treatment. According to government healthcare facilities, hospitals have reimbursement plans and advanced technology systems for sepsis treatment. Growth of the segment can be attributed to an increase in number of hospital facilities across the world.

Sepsis Treatment Market: Regional Segmentation

  • In terms of region, the global sepsis treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to be a highly attractive market during the forecast period. Well-established healthcare and life science industries, early adoption of technologically advanced products, high awareness about various infectious as well as chronic diseases, and high per capita healthcare expenditure are the major factors attributed to North America’s large market share in 2020.
  • The sepsis treatment market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Increase in disposable income & purchasing power of consumers, rise in biotechnology, research institutes, and research funding by government & private bodies, expansion of healthcare infrastructure, large population base, and increase in incidence of sepsis related disorders are expected to augment the sepsis treatment market in Asia Pacific during the forecast period. Economic growth of China, India, Indonesia, and other countries in Southeast Asia is likely to increase healthcare expenditure, which is projected to drive the sepsis treatment market in the region.

Sepsis Treatment Market: Major Players

  • Key players operating in the global sepsis treatment market include
    • Baxter International, Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Nipro Corporation
    • Asahi Kasei
    • B. Braun Group
    • CytoSorbents Corporation
    • Medtronic plc
    • Nikkiso Co., Ltd.
    • Medica SPA
    • Toray Industries
    • Merck & Co., Inc.
  • These players focus on adopting various strategies to expand product offerings and to strengthen geographic presence across the globe. Technological advancements, mergers & acquisitions, expansion of product portfolio, and increase in research & development activities are the strategies adopted by the companies to expand business in the global sepsis treatment market.

Sepsis Treatment Market – Segmentation

Type
  • Severe Sepsis
  • Sepsis Shock
  • Sepsis in Need of Blood Purification
Therapy
  • Continuous Renal Replacement Therapies (CRRT)
  • Intermittent Hemodialysis
  • Sustained Low-efficiency Daily Dialysis (SLEDD)
  • Others
End User
  • Hospitals
  • Specialty Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of sepsis treatment market?

Sepsis treatment market was valued over US$ 600 Mn in 2020 and is expected to reach US$ 1.6 Bn by the end of 2031

What are the key driving factors for the growth of the sepsis treatment market?

Sepsis treatment market is driven by increase in number of product launches and collaborations among players

Which is the rising prominent segment in the sepsis treatment market?

The severe sepsis segment accounted for significant share of the global sepsis treatment market, the segment's dominance can be attributed to increase in patient population with infectious diseases such as COVID-19

What are the end-use segments in the sepsis treatment market?

The hospitals segment accounted for major share of the sepsis treatment market, hospitals are an important channel for sepsis treatment

Who are the key players in the global sepsis treatment market?

Key players in the global sepsis treatment market include Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, Asahi Kasei, B. Braun Group, CytoSorbents Corporation

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Sepsis Treatment Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Market Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Sepsis Treatment Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Sepsis Population (admissions as % of population)

        5.2. Total Sepsis Hospital Admissions [general ward & other, ICU patients admitted (000)]

        5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

        5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Sepsis Treatment Market Analysis and Forecast, by Type 

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

            6.3.1. Severe Sepsis

            6.3.2. Septic Shock

            6.3.3. Sepsis in Need of Blood Purification

        6.4. Global Sepsis Treatment Market Attractiveness Analysis, by Type

    7. Global Sepsis Treatment Market Analysis and Forecast, by Therapy 

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

            7.3.1. Continuous Renal Replacement Therapies (CRRT)

            7.3.2. Intermittent Hemodialysis

            7.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

            7.3.4. Others

        7.4. Global Sepsis Treatment Market Attractiveness Analysis, by Therapy 

    8. Global Sepsis Treatment Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Specialty Centers

            8.3.3. Others

        8.4. Global Sepsis Treatment Market Attractiveness Analysis, by End-user 

    9. Global Sepsis Treatment Market Analysis and Forecast, by Region 

        9.1. Key Findings

        9.2. Global Sepsis Treatment Market Value (US$ Bn) Forecast, by Region

            9.2.1. North America

            9.2.2. Europe 

            9.2.3. Asia Pacific

            9.2.4. Latin America 

            9.2.5. Middle East & Africa

        9.3. Global Sepsis Treatment Market Attractiveness Analysis, by Region

    10. North America Sepsis Treatment Market Analysis and Forecast

        10.1.  Introduction

            10.1.1.  Key Findings

        10.2. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type , 2017–2031

            10.2.1. Severe Sepsis

            10.2.2. Septic Shock

            10.2.3. Sepsis in Need of Blood Purification

        10.3. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

            10.3.1. Continuous Renal Replacement Therapies (CRRT)

            10.3.2. Intermittent Hemodialysis

            10.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

            10.3.4. Others

        10.4. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

            10.4.1. Hospitals

            10.4.2. Specialty Centers

            10.4.3. Others

        10.5. North America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. North America Sepsis Treatment Market Attractiveness Analysis

            10.6.1. By Type 

            10.6.2. By Therapy 

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Sepsis Treatment Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

            11.2.1. Severe Sepsis

            11.2.2. Septic Shock

            11.2.3. Sepsis in Need of Blood Purification

        11.3. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

            11.3.1. Continuous Renal Replacement Therapies (CRRT)

            11.3.2. Intermittent Hemodialysis

            11.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

            11.3.4. Others

        11.4. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

            11.4.1. Hospitals

            11.4.2. Specialty Centers

            11.4.3. Others

        11.5. Europe Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Europe Sepsis Treatment Market Attractiveness Analysis

            11.6.1. By Type 

            11.6.2. By Therapy 

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Sepsis Treatment Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

            12.2.1. Severe Sepsis

            12.2.2. Septic Shock

            12.2.3. Sepsis in Need of Blood Purification

        12.3. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

            12.3.1. Continuous Renal Replacement Therapies (CRRT)

            12.3.2. Intermittent Hemodialysis

            12.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

            12.3.4. Others

        12.4. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by End-user, 2017–2031

            12.4.1. Hospitals

            12.4.2. Specialty Centers

            12.4.3. Others

        12.5. Asia Pacific Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India 

            12.5.4. Australia & New Zealand 

            12.5.5. Rest of Asia Pacific

        12.6. Asia Pacific Sepsis Treatment Market Attractiveness Analysis

            12.6.1. By Type

            12.6.2. By Therapy 

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Sepsis Treatment Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

            13.2.1. Severe Sepsis

            13.2.2. Septic Shock

            13.2.3. Sepsis in Need of Blood Purification

        13.3. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

            13.3.1. Continuous Renal Replacement Therapies (CRRT)

            13.3.2. Intermittent Hemodialysis

            13.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

            13.3.4. Others

        13.4. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

            13.4.1. Hospitals

            13.4.2. Specialty Centers

            13.4.3. Others

        13.5. Latin America Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Latin America Sepsis Treatment Market Attractiveness Analysis

            13.6.1. By Type

            13.6.2. By Therapy

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Sepsis Treatment Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Type, 2017–2031

            14.2.1. Severe Sepsis

            14.2.2. Septic Shock

            14.2.3. Sepsis in Need of Blood Purification

        14.3. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

            14.3.1. Continuous Renal Replacement Therapies (CRRT)

            14.3.2. Intermittent Hemodialysis

            14.3.3. Sustained Low-efficiency Daily Dialysis (SLEDD)

            14.3.4. Others

        14.4. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

            14.4.1. Hospitals

            14.4.2. Specialty Centers

            14.4.3. Others

        14.5. Middle East & Africa Sepsis Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries 

            14.5.2. South Africa 

            14.5.3. Rest of Middle East & Africa

        14.6. Middle East & Africa Sepsis Treatment Market Attractiveness Analysis

            14.6.1. By Type

            14.6.2. By Therapy 

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competitive Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2.  Company Profiles

            15.2.1. Baxter International, Inc.

                15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.1.2. Financial Overview

                15.2.1.3. Product Portfolio

                15.2.1.4. Strategic Overview

                15.2.1.5. SWOT Analysis

            15.2.2. Fresenius Medical Care AG & Co. KGaA 

                15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.2.2. Financial Overview

                15.2.2.3. Product Portfolio

                15.2.2.4. Strategic Overview

                15.2.2.5. SWOT Analysis

            15.2.3. Nipro Corporation

                15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.3.2. Financial Overview

                15.2.3.3. Product Portfolio

                15.2.3.4. Strategic Overview

                15.2.3.5. SWOT Analysis

            15.2.4. Asahi Kasei 

                15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.4.2. Financial Overview

                15.2.4.3. Product Portfolio

                15.2.4.4. Strategic Overview

                15.2.4.5. SWOT Analysis

            15.2.5. B. Braun Group

                15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.5.2. Product Portfolio

                15.2.5.3. Strategic Overview

                15.2.5.4. SWOT Analysis

            15.2.6. CytoSorbents Corporation

                15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.6.2. Financial Overview

                15.2.6.3. Product Portfolio

                15.2.6.4. Strategic Overview

                15.2.6.5. SWOT Analysis

            15.2.7. Medtronic plc

                15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.7.2. Financial Overview

                15.2.7.3. Product Portfolio

                15.2.7.4. Strategic Overview

                15.2.7.5. SWOT Analysis

            15.2.8. Nikkiso Co., Ltd.

                15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.8.2. Financial Overview

                15.2.8.3. Product Portfolio

                15.2.8.4. Strategic Overview

                15.2.8.5. SWOT Analysis

            15.2.9. Medica SPA

                15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.9.2. Financial Overview

                15.2.9.3. Product Portfolio

                15.2.9.4. Strategic Overview

                15.2.9.5. SWOT Analysis

            15.2.10. Toray Industries

                15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.10.2. Financial Overview

                15.2.10.3. Product Portfolio

                15.2.10.4. Strategic Overview

                15.2.10.5. SWOT Analysis

            15.2.11. Merck & Co., Inc.

                15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.2.11.2. Financial Overview

                15.2.11.3. Product Portfolio

                15.2.11.4. Strategic Overview

                15.2.11.5. SWOT Analysis

    List of Tables

    Table 01: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 02: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 03: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Sepsis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 07: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 08: North America Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 11: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 12: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 15: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 16: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 19: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 20: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 23: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by Therapy, 2017–2031

    Table 24: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031 

    List of Figures

    Figure 01: Global Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Sepsis Treatment Market Value Share, by Type, 2020

    Figure 03: Global Sepsis Treatment Market Value Share, by Therapy, 2020

    Figure 04: Global Sepsis Treatment Market Value Share, by End-user, 2020

    Figure 05: Global Sepsis Treatment Market Value Share, by Region, 2020

    Figure 06: Global Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 07: Global Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 08: Global Sepsis Treatment Market Revenue (US$ Mn), by Severe Sepsis/Sepsis, 2017–2031

    Figure 09: Global Sepsis Treatment Market Revenue (US$ Mn), by Septic Shock, 2017–2031

    Figure 10: Global Sepsis Treatment Market Revenue (US$ Mn), by Sepsis in Need of Blood Purification, 2017–2031

    Figure 11: Global Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

    Figure 12: Global Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

    Figure 13: Global Sepsis Treatment Market Revenue (US$ Mn), by Continuous Renal Replacement Therapies (CRRT), 2017–2031

    Figure 14: Global Sepsis Treatment Market Revenue (US$ Mn), by Intermittent Hemodialysis, 2017–2031

    Figure 15: Global Sepsis Treatment Market Revenue (US$ Mn), by Sustained Low-efficiency Daily Dialysis (SLEDD), 2017–2031

    Figure 16: Global Sepsis Treatment Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 17: Global Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 18: Global Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 19: Global Sepsis Treatment Market Revenue (US$ Mn), by Hospitals, 2017–2031

    Figure 20: Global Sepsis Treatment Market Revenue (US$ Mn), by Specialty Centers, 2017–2031

    Figure 21: Global Sepsis Treatment Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 22: Global Sepsis Treatment Market Value Share Analysis, by Region, 2020 and 2031

    Figure 23: Global Sepsis Treatment Market Attractiveness Analysis, by Region, 2021–2031

    Figure 24: North America Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 25: North America Sepsis Treatment Market Value Share Analysis, by Country, 2020 and 2031

    Figure 26: North America Sepsis Treatment Market Attractiveness Analysis, by Country, 2021–2031

    Figure 27: North America Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 28: North America Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 29: North America Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

    Figure 30: North America Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

    Figure 31: North America Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 32: North America Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 33: Europe Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 34: Europe Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 35: Europe Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 36: Europe Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 37: Europe Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 38: Europe Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

    Figure 39: Europe Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

    Figure 40: Europe Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 41: Europe Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 42: Asia Pacific Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 43: Asia Pacific Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 44: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 45: Asia Pacific Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 46: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 47: Asia Pacific Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

    Figure 48: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

    Figure 49: Asia Pacific Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 50: Asia Pacific Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 51: Latin America Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 52: Latin America Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 53: Latin America Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 54: Latin America Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 55: Latin America Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 56: Latin America Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

    Figure 57: Latin America Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

    Figure 58: Latin America Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 59: Latin America Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 60: Middle East & Africa Sepsis Treatment Market Value (US$ Mn) Forecast, 2017–2031

    Figure 61: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 62: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 63: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by Type, 2020 and 2031

    Figure 64: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by Type, 2021–2031

    Figure 65: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by Therapy, 2020 and 2031

    Figure 66: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by Therapy, 2021–2031

    Figure 67: Middle East & Africa Sepsis Treatment Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 68: Middle East & Africa Sepsis Treatment Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 69: Global Sepsis Treatment Market Share, by Company, 2019

    Figure 70: Baxter International, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

    Figure 71: Fresenius Medical Care AG & Co. KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

    Figure 72: Nipro Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

    Figure 73: Asahi Kasei Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

    Figure 74: B. Braun Group Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

    Figure 75: CytoSorbents Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

    Figure 76: Medtronic Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 77: NIKKISO CO., LTD Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 78: Toray Industries Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 79: Merck & Co. Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Copyright © Transparency Market Research, Inc. All Rights reserved